Bob Silverman

Bob Silverman

Consultant / Advisor chez
The New York City Investment Fund Manager, Inc.
Finance
Consumer Services
Commercial Services

Profil

Bob A. Silverman currently works at The New York City Investment Fund Manager, Inc., as Advisor and C2i Genomics, Inc., as Chief Business Officer from 2023.
Mr. Silverman also formerly worked at Biohealth Innovation, Inc., as Director, Roche Holding AG, as Venture Capital Lead from 2012 to 2020, Pennie & Edmonds LLP, as Associate, Alloy Therapeutics LLC, as Executive Partner & Chief Business Officer from 2019 to 2021, and Rejuveron Life Sciences AG, as Chief Business Officer from 2021 to 2022.
Mr. Silverman received his undergraduate degree from Franklin & Marshall College and graduate degree from Boston University School of Law.

Postes actifs de Bob Silverman

SociétésPosteDébut
Consultant / Advisor -
Corporate Officer/Principal 01/01/2023

Anciens postes connus de Bob Silverman

SociétésPosteFin
Corporate Officer/Principal 01/12/2022
Corporate Officer/Principal 01/07/2021
ROCHE HOLDING AG Conseiller Juridique Général 31/12/2003
Corporate Officer/Principal 31/12/1993
Directeur/Membre du Conseil -
Voir l'expérience en détail de Bob Silverman

Formation de Bob Silverman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

63

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Commercial Services

Consumer Services

Finance

Consumer Services

Finance

Commercial Services

Technology Services

Finance

  1. Bourse
  2. Insiders
  3. Bob Silverman